ClinicalTrials.gg
CompletedNCT02842879Updated Jul 25, 2016

Outpatient Foley Cervix Priming

An interventional study of Outpatient Foley cervix priming in Outpatient Mechanical Cervix Priming, sponsored by Hospital de Santa Maria, Portugal. Completed. Open to female participants aged 15 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-07-25.

Sponsored by Hospital de Santa Maria, Portugal · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
15 Years to 45 Years
Sex
Female
01

Study summary

The aim was to conduct a non-blinded prospective randomized study at a tertiary hospital. Inclusion criteria: term pregnancy with a single fetus in cephalic presentation, Bishop score \< 6, gestational age > 41 weeks or medical indication for induction of labor.

Patients will be randomized to outpatient or inpatient cervix priming with Foley catheter.

The primary outcome will be to compare the variation of Bishop score (difference between Bishop score before and after application of Foley catheter) between outpatient and inpatient groups. Secondary comparisons include: mode of delivery, Foley catheter application-to-delivery time, inpatient time, sequential use of prostaglandins, infection and maternal pain.

02

Conditions studied

  • Outpatient Mechanical Cervix Priming
03

In context

Lead sponsor

Hospital de Santa Maria, Portugal is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • women with a single fetus in cephalic presentation
  • Bishop score \< 6
  • Gestational age > 41 weeks or medical indication for induction of labor submitted to cervix priming with Foley catheter

Exclusion criteria

Exclusion Criteria:

  • women with a fetus in noncephalic presentation
  • an indication for elective cesarean delivery
  • spontaneous labor
  • hydramnios (amniotic fluid index ≥ 25)
  • nonreassuring cardiotocogram
  • multiple pregnancy
  • rupture of membranes
  • active vaginal bleeding
  • indication for prophylaxis of Streptococcus group B infection
  • infection
  • cervical injury
  • previous cesarean section with recurrent indication
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Outpatient Foley cervix priming

    Patients randomized to outpatient cervix priming will have the insertion of the catheter in the same conditions defined by the Department protocol for inpatient cervix priming. They will be discharged after a reassuring cardiotocogram following the introduction of the Foley catheter. When discharged, the patients will be instructed to apply manual traction to the catheter every 6 hours and they will be given a written document with all the information that should bring them back to hospital.

    Other: Outpatient Foley cervix priming

  • No intervention
    Inpatient Foley cervix priming

    The introduction of a deflated catheter (Foley catheter nº 16F) through the outer cervix orifice is preceded by iodine disinfection of the cervix. The intracervical catheter is distended with 40mL of a saline solution. The end of the catheter is taped to the medial portion of the thigh and manual traction is applied to the catheter every 6 hours. If it is not spontaneously extruded it is removed after 24h. Cervix priming occurs in an inpatient setting.

Interventions

  • OtherOutpatient Foley cervix priming

    Outpatient setting for cervix priming with Foley catheter

06

What researchers measure

Primary outcomes

  1. variation of bishop score (difference between bishop score before and after application of foley catheter)

    Time frame: up to 24 months

Secondary outcomes

  1. mode of delivery

    Time frame: up to 24 months

  2. induction-to-delivery time

    Time frame: up to 24 months

  3. maternal pain evaluated by visual analog scale for pain

    Time frame: up to 24 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Alfirevic Z, Gyte GM, Nogueira Pileggi V, Plachcinski R, Osoti AO, Finucane EM. Home versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD007372. doi: 10.1002/14651858.CD007372.pub4. PubMed 32852803 ↗
  • Policiano C, Pimenta M, Martins D, Clode N. Outpatient versus inpatient cervix priming with Foley catheter: A randomized trial. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:1-6. doi: 10.1016/j.ejogrb.2016.11.026. Epub 2016 Nov 27. PubMed 27923165 ↗

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2014, a primary completion of Dec 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2016
First posted
Jul 25, 2016
Start
Jan 2014
Primary completionActual
Dec 2015
CompletionActual
Dec 2015
Last update
Jul 25, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 25, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02842879
Lead sponsor
Hospital de Santa Maria, Portugal
Responsible party
Catarina Policiano (Dr. Catarina Policiano, Hospital de Santa Maria, Portugal) — Principal investigator
First posted
Jul 25, 2016
Start date
Jan 2014
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Jul 25, 2016

Study contacts

Catarina Policiano, MD
principal investigator · Hospital de Santa Maria, Centro Hospitalar Lisboa Norte

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion